Quality by design modelling to support rapid RNA vaccine production against emerging infectious diseases. (2021)
Attributed to:
Meeting the UK demand for COVID19/SARS-CoV-2 vaccines via integrated manufacturing and supply chain optimisation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-021-00322-7
PubMed Identifier: 33927197
Publication URI: http://europepmc.org/abstract/MED/33927197
Type: Journal Article/Review
Volume: 6
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105